Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Seya Industries Ltd

SEYAIND
NSE
13.62
1.95%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Seya Industries Ltd

SEYAIND
NSE
13.62
1.95%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
36Cr
Close
Close Price
13.62
Industry
Industry
Chemicals - Speciality
PE
Price To Earnings
PS
Price To Sales
-7.03
Revenue
Revenue
-5Cr
Rev Gr TTM
Revenue Growth TTM
-176.98%
PAT Gr TTM
PAT Growth TTM
189.87%
Peer Comparison
How does SEYAIND stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SEYAIND
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
22312320-5000
Growth YoY
Revenue Growth YoY%
-89.3-87.2-69.8-82.3-37.627.0-25.5-100.0-434.4-100.0-100.0
Expenses
ExpensesCr
1111112111110
Operating Profit
Operating ProfitCr
-9120011-1-6-1-10
OPM
OPM%
-345.345.167.320.827.918.857.0122.9
Other Income
Other IncomeCr
222233236544
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
445544554644
PBT
PBTCr
-10-1-1-2-1-1-1-2-5-1-1-1
Tax
TaxCr
000000000-1-1-1
PAT
PATCr
-10-10-2000-1-4-1-1-1
Growth YoY
PAT Growth YoY%
-83.6-251.695.481.896.388.7-45.523.0-1,091.9-463.6-190.657.8
NPM
NPM%
-408.1-42.9-7.2-159.2-24.0-3.8-14.085.6
EPS
EPS
-3.8-0.4-0.1-0.7-0.10.0-0.1-0.6-1.7-0.2-0.3-0.2

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
24827531434841325844663780-5
Growth
Revenue Growth%
88.611.214.110.818.6-37.5-83.049.2-43.5-78.3-100.0
Expenses
ExpensesCr
214227240242275190455654453
Operating Profit
Operating ProfitCr
33487410513868-19-174-5-8
OPM
OPM%
13.517.523.530.333.526.2-1.914.1-46.346.4163.5
Other Income
Other IncomeCr
121129-921991519
Interest Expense
Interest ExpenseCr
10131418188000000
Depreciation
DepreciationCr
111114151617181818181819
PBT
PBTCr
1426477410652-110-7-26-5-8-9
Tax
TaxCr
10521185-1-1-1-2-2-2
PAT
PATCr
132742528847-110-6-25-3-6-7
Growth
PAT Growth%
288.3105.557.724.168.9-46.9-333.194.3-292.985.9-81.7-4.3
NPM
NPM%
5.39.713.415.121.418.2-249.0-9.6-66.5-43.1127.8
EPS
EPS
11.824.428.223.336.019.1-41.3-2.4-9.3-1.3-2.4-2.5

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
111120252527272727272727
Reserves
ReservesCr
5478280716801945835829805801795793
Current Liabilities
Current LiabilitiesCr
6562871176597989591919091
Non Current Liabilities
Non Current LiabilitiesCr
339416334458619704764693693694696696
Total Liabilities
Total LiabilitiesCr
6207187921,3161,6141,7731,7241,6441,6151,6121,6081,607
Current Assets
Current AssetsCr
109148141188184203885532292725
Non Current Assets
Non Current AssetsCr
5115706501,1281,4301,5701,6361,5881,5831,5831,5811,582
Total Assets
Total AssetsCr
6207187921,3161,6141,7731,7241,6441,6151,6121,6081,607

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
14166974952-9121-10-17
Investing Cash Flow
Investing Cash FlowCr
-59-71-137-169-287-847-7-4915
Financing Cash Flow
Financing Cash FlowCr
315568109180812-5312
Net Cash Flow
Net Cash FlowCr
-150013-13-101-100
Free Cash Flow
Free Cash FlowCr
1416697495-92-8131-10-17
CFO To PAT
CFO To PAT%
104.858.1163.2140.7106.93.28.2-193.0-2.6302.3270.9
CFO To EBITDA
CFO To EBITDA%
40.832.393.269.968.42.21,091.7130.7-3.8-280.9321.3

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
01516071,4301,12710413394575235
Price To Earnings
Price To Earnings
0.06.014.427.312.72.40.00.00.00.00.0
Price To Sales
Price To Sales
0.00.61.94.12.70.43.01.41.56.5
Price To Book
Price To Book
0.01.71.61.91.40.10.10.10.10.10.0
EV To EBITDA
EV To EBITDA
5.511.113.418.412.812.9-1,090.992.5-48.0220.0-151.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
17.821.226.941.949.742.537.955.37.5100.0
OPM
OPM%
13.517.523.530.333.526.2-1.914.1-46.346.4
NPM
NPM%
5.39.713.415.121.418.2-249.0-9.6-66.5-43.1
ROCE
ROCE%
9.48.28.97.28.43.4-6.8-0.5-1.6-0.3-0.5
ROE
ROE%
20.030.114.17.110.74.8-12.7-0.7-3.0-0.4-0.8
ROA
ROA%
2.13.75.34.05.52.6-6.4-0.4-1.5-0.2-0.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
**Seya Industries Ltd** is an Indian specialty chemical manufacturer currently navigating a complex **Corporate Insolvency Resolution Process (CIRP)**. Historically a significant player in the benzene-based chemistry space, the company is presently focused on operational survival, debt restructuring, and the preservation of its integrated manufacturing assets. --- ### **Core Manufacturing Competencies & Integrated Value Chain** The company specializes in the manufacture of **Specialty Chemical Intermediates** and **Organic Chemical Intermediates**. Its business model is built on a **backward and forward integrated** structure designed to convert base chemicals into high-margin downstream products. * **Niche Chemistries:** The company possesses the technical expertise to execute complex and hazardous chemical processes at scales ranging from **kilograms to several tons**. * **Technology Moat:** Seya utilizes specialized know-how licensed from **German technology suppliers**, protected by **20-year confidentiality agreements**. * **Strategic Integration:** The manufacturing facility is designed for captive consumption; **50%** of proposed greenfield capacity is intended for internal use, positioning the company as a potential **lowest-cost producer** through value-chain optimization. * **Manufacturing Base:** Operations are centered at **T-13/T-14, Tarapur Industrial Area, MIDC, Boisar (Maharashtra)**. --- ### **Diversified End-User Applications** Seya’s product portfolio serves a broad spectrum of essential and industrial global sectors: | End-User Segment | Key Applications & Products | | :--- | :--- | | **Agrochemicals** | Insecticides and Pesticides (e.g., **DDT**, **Quinalphos**, **Mortein**, **Baygon**) | | **Pharmaceuticals** | Intermediates for **Paracetamol** and **Floxacins** | | **Personal & Health Care** | Ingredients for **Hair dyes** and hygiene products | | **Printing & Pigments** | **Computer Printing Inks**, **Laser/Inkjet inks**, Paints, and **Road Markings** | | **Industrial & Textiles** | **Thermic fluids** (heating mediums), **Rubber chemicals**, and **Textile dyes** | --- ### **Current Operational Status & Capacity Constraints** Manufacturing operations are **presently suspended** or severely restricted due to a combination of financial and regulatory factors: * **Liquidity Crunch:** A severe paucity of working capital has halted active production. * **Environmental Restrictions:** Prior to suspension, operations were limited to **30–40% capacity utilization** due to effluent discharge limits imposed by the **National Green Tribunal (NGT)**. * **ZLD Transition:** A priority strategic goal is the implementation of **Zero Liquid Discharge (ZLD)** technology to bypass current NGT restrictions and resume full-scale production. --- ### **Financial Performance & Solvency Metrics** The company has experienced a sharp decline in revenue and persistent losses, exacerbated by the classification of its credit facilities as **Non-Performing Assets (NPA)**. | Metric (₹ in Lakhs) | FY 2024-25 (Est/Interim) | FY 2023-24 (Audited) | FY 2022-23 (Audited) | | :--- | :--- | :--- | :--- | | **Total Revenue** | *Monitoring* | **1,713.64** | **4,615.16** | | **Revenue from Operations** | *Monitoring* | **805.84** | **3,711.22** | | **Profit / (Loss) After Tax** | **(630.69)** | **(345.39)** | **(2,467.98)** | | **Basic EPS (₹)** | *Monitoring* | **(1.31)** | **(9.29)** | | **Total Assets** | **1,61,231.77** | **1,61,231.77** | **1,64,364.23** | *Note: FY 2024-25 figures reflect the ongoing monitoring period under CIRP.* --- ### **Insolvency Status & Governance Under CIRP** Seya Industries is currently under the **Corporate Insolvency Resolution Process (CIRP)** following an order by the **Hon’ble NCLT (Mumbai Bench)** on **November 2, 2023**. * **Leadership:** The powers of the Board of Directors are **suspended**. Operations are managed by the **Interim Resolution Professional (IRP)**, Mr. Bhavesh Rathod, to maintain the company as a **"Going Concern."** * **Legal Stay:** The **NCLAT** issued a stay on the constitution of the **Committee of Creditors (CoC)** on **December 6, 2024**, which remains in force as of **September 2025**. * **Management Continuity:** Despite the CIRP, **Mr. Ashok G Rajani** was re-appointed as Managing Director & CEO for a **5-year term** (2024–2029) to provide technical and strategic continuity. --- ### **Debt Profile & Interest Non-Provision Dispute** A significant portion of the company’s financial distress stems from a protracted legal battle with its lenders regarding committed funding for expansion. * **Unprovided Interest:** The company has **ceased providing for interest costs** on several credit facilities, arguing that lenders failed to fulfill lending obligations. * **Contingent Liabilities:** As of March 31, 2025, unprovided interest amounted to **₹14,260.77 Lakhs**. If these contractual interests were recognized, total liabilities would escalate to **₹1,59,972.84 Lakhs**. * **Default Status:** Principal outstanding in default includes **₹69,601.68 Lakhs** in Term Loans and **₹7,696.65 Lakhs** in Working Capital. --- ### **Strategic Turnaround & Growth Catalysts** Management’s recovery strategy focuses on cost rationalization and capitalizing on structural shifts in the global chemical market: * **Mega Green-Field Project:** A **₹600 crore** investment at MIDC Tarapur is currently on hold. Once operational at **80% capacity**, it is projected to generate **₹1,000–1,200 crore** in annual revenue. * **Austerity Measures:** Implementation of **workforce rationalization**, **pay cuts**, and the suspension of all **discretionary capital expenditure** to preserve cash. * **"China Plus One" Opportunity:** The company aims to capture market share as global buyers diversify away from China due to rising costs and environmental crackdowns. * **Import Substitution:** Aligning with **"Make in India"** initiatives to replace imported chemical intermediates with locally manufactured alternatives. --- ### **Critical Risk Factors for Investors** * **Going Concern Uncertainty:** Auditors have repeatedly highlighted material uncertainty regarding the company’s ability to continue operations, as current liabilities exceed current assets by **₹6,394.99 Lakhs**. * **Regulatory & Legal Headwinds:** The company faces a **SEBI Final Order** (issued May 2, 2025), currently under an interim stay by the **Securities Appellate Tribunal (SAT)**. * **Macroeconomic Volatility:** The **Russia-Ukraine war** and recessionary trends in **Europe and the US** have led to volatile raw material costs and a decline in global demand for specialty intermediates. * **Operational Hazards:** High exposure to environmental regulations regarding hazardous waste and effluent treatment; failure to meet **Zero Liquid Discharge** targets could permanently impair production capacity.